Indications : התוויות

4.1. Therapeutic indications

By intramuscular or intravenous route

Dexamethasone Kern Pharma is indicated in the treatment of:
• Endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.
• Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in bronchial asthma, contact or atopic dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.
• Ophthalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.
• Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis.
• Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides).
• Respiratory diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome).
• Hematological: acquired (autoimmune) hemolytic anemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia.
• Nephrotic syndrome of the idiopathic type or that due to lupus erythematosus.
• Cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis.
• Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemic-onset form (Still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, SLE, temporal arteritis.
•   Infectious Diseases: Bacterial meningitis – adjunct to antibiotics in suspected Pneumococcal meningitis and TB meningitis. Severe infectious diseases with toxic states (e.g tuberculosis, typhoid, brucellosis; Only with simultaneous anti-infective therapy).
•   Fetal lung maturation.
•   Chemotherapy – associated nausea and vomiting.
•   Multiple Myeloma – part of chemotherapy protocols (e.g VAD).
•   Prevention and treatment of acute mountain sickness/HACE.